We found that HJJPD reduces hyperleptinemia, alleviates chronic inflammatory response, improves leptin resistance of obese mice, and plays a role in treating simple obesity by activating the LEP-mediated JAK2-STAT3 signaling pathway in liver and adipose tissue. The gene discussed is JAK2; the disease is obesity due to melanocortin 4 receptor deficiency.